Giotrif
Generic name:
Pharmacist-reviewed drug information from the RxWiki encyclopedia.
Overview
Giotrif is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC) whose tumors express a specific type of gene mutation. This mutation is of the epidermal growth factor receptor (EGFR).
Giotrif belongs to a group of drugs called tyrosine kinase inhibitors which block proteins that promote the development of cancerous cells.
This medication comes in tablet form and is taken typically once a day, without food. Do not eat food for at least 3 hours before and at least 1 hour after taking Giotrif.
Common side effects of Giotrif include diarrhea, skin related side effects such as rash and dry skin, and mouth sores.
All information on this site is provided “as-is” for informational purposes only and is not a substitute for medical advice or treatment. You should consult with a medical professional if you have any questions about your health.